Adimab
Premier Human Antibody Discovery and Engineering Company
Klus Pharma Inc.
Discovery and development of novel and safer antibody-based therapeutics.
Side-by-Side Comparison
| Metric | Adimab | Klus Pharma Inc. |
|---|---|---|
| Founded | 2007 | 2014 |
| Headquarters | Lebanon, United States | Princeton, United States |
| Employees | 137 | 11 |
| Industry | Biotechnology, Health Care, Health and Wellness | Manufacturing, Pharmaceutical, Marketing |
| Funding Stage | Series Unknown | Not tracked yet |
| Total Funding | Not tracked yet | Not tracked yet |
| Funding Rounds | 8 | Not tracked yet |
| Business Model | B2B, Platform, On Demand | Not tracked yet |
| Revenue Model | Licensing, Project Based, Performance Based | Not tracked yet |
| Services | Antibody Discovery Platform, Antibody Engineering, Protein and TCR Engineering, Multispecific Antibodies, Funded Discovery, Platform Transfer | Not tracked yet |
| Target Customers | Biopharmaceutical Companies, Biotechnology Firms, Clinical Research Organizations, Drug Development Teams, Pharmaceutical Manufacturers | Not tracked yet |
| Taxonomy | Antibody Discovery, Biopharmaceutical Collaborations, Yeast-Based Platform, Antibody Engineering, Therapeutic Leads, Protein Modality Development, T Cell Engagers, Fc & Fab Heterodimerization, Custom Antibody Discovery, Chain Exchange Technology, AI & ML Guided Library Design, Soluble TCR Optimization, Bi- & Multispecific Antibodies, Antibody Optimization, Therapeutics Pipeline Expansion | Biologics Drug Discovery And Development, Antibody Discovery, Antibody-drug Conjugates (ADC), Clinical Development, Bispecific Antibodies, Multispecific Antibodies, Immuno-oncology |
| Website | adimab.com | kluspharma.com |
About Adimab
Adimab, founded in 2007, positions itself as a premier player in antibody discovery and engineering, serving as a favored partner within the biopharma sector. The company leverages a proprietary yeast-based platform, which facilitates the comprehensive discovery and optimization of human antibodies...
About Klus Pharma Inc.
Klus Pharma Inc. is a subsidiary of Kelun Group and affiliated with Kelun-Biotech, focusing on the discovery and development of advanced therapeutic biotechnologies. Established in 2014, the company's primary aim is to address the unmet needs of patients suffering from various severe disorders such...
Frequently Asked Questions
Track both companies in real time
Signal Tracker monitors Adimab, Klus Pharma Inc., and millions of companies for 40+ signal types.